InsidersTradesSigma
Track the 엔지켐생명과학 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엔지켐생명과학 has published 9 reports. Market capitalisation: €83.8bn. The latest transaction was reported on 7 July 2026 (Other). Among the most active insiders: 남윤희. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
엔지켐생명과학 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para el cuidado de la salud.